Condensed Consolidated Statements of Income [Abstract] | |
Revenue | 239.65M |
Cost of goods sold (excluding amortization of purchased technology) | 59.2M |
Gross Profit | 180.45M |
Operating expenses: | |
Sales, marketing and administrative | 131.89M |
Research and development | 12.52M |
Amortization of intangible assets | |
Total operating expenses | 159.29M |
Interest and other expense, net: | |
Interest income | 190K |
Interest expense | -10.98M |
Other income (expense), net | 94K |
Total interest and other expense, net | |
Income before income tax expense | |
Income tax expense | -6.97M |
Consolidated net income | 3.5M |
Net loss attributable to noncontrolling interests | -431K |
Net income attributable to NuVasive, Inc. | 3.93M |
Net income per share attributable to NuVasive, Inc.: | |
Basic | 0.08 |
Diluted | 0.07 |
Weighted average shares outstanding: | |
Basic | 50.26M |
Diluted | 55.78M |